NO20013464L - Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner - Google Patents

Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner

Info

Publication number
NO20013464L
NO20013464L NO20013464A NO20013464A NO20013464L NO 20013464 L NO20013464 L NO 20013464L NO 20013464 A NO20013464 A NO 20013464A NO 20013464 A NO20013464 A NO 20013464A NO 20013464 L NO20013464 L NO 20013464L
Authority
NO
Norway
Prior art keywords
isoxazolidinones
infections
treatment
hydroxylamino
acids
Prior art date
Application number
NO20013464A
Other languages
English (en)
Other versions
NO20013464D0 (no
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/de
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of NO20013464D0 publication Critical patent/NO20013464D0/no
Publication of NO20013464L publication Critical patent/NO20013464L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Oppfinnelsen angår medikamenter som omfatter i det minste en forbindelse med den generelle formel (I) *S Ri O R4 1 l II l Rs-C-C-C- N-0-R3 Ri R2 og deres anvendelse for terapeutisk og profylaktisk behandling av infeksjoner i mennesker og dyr forårsaket av bakterier, sopp'og parasitter.
NO20013464A 1999-01-13 2001-07-12 Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner NO20013464L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19903666A DE19903666A1 (de) 1999-01-13 1999-01-30 Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung
PCT/EP2000/000165 WO2000041473A2 (de) 1999-01-13 2000-01-12 Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen

Publications (2)

Publication Number Publication Date
NO20013464D0 NO20013464D0 (no) 2001-07-12
NO20013464L true NO20013464L (no) 2001-09-12

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013464A NO20013464L (no) 1999-01-13 2001-07-12 Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner

Country Status (14)

Country Link
EP (1) EP1143941A3 (no)
JP (1) JP2002534440A (no)
CN (1) CN1342078A (no)
AU (1) AU2436600A (no)
BR (1) BR0007491A (no)
CA (1) CA2360366A1 (no)
CZ (1) CZ20012380A3 (no)
HU (1) HUP0105412A2 (no)
IL (1) IL143795A0 (no)
NO (1) NO20013464L (no)
PL (1) PL350128A1 (no)
SK (1) SK9502001A3 (no)
TR (1) TR200102019T2 (no)
WO (1) WO2000041473A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial preparations containing a compound of the type 3-fluoro-D-alanine and a cyclocarrin compound that is converted in the nitrogen atom
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouvelles rifamycines
DE3686632T2 (de) * 1985-04-30 1993-01-21 Takeda Chemical Industries Ltd Antibiotische derivate, ihre herstellung und verwendung.
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119462A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 五員環n−スルホ化合物
JPS63119476A (ja) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd イソキサゾリドン誘導体
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
GB2290543B (en) * 1993-03-16 1996-05-22 British Biotech Pharm Hydroxamic acid derivatives as metalloproteinase inhibitors
NZ271893A (en) * 1993-08-23 1997-11-24 Immunex Corp Inhibitors of tnf-alpha secretion
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (en) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
WO1998043959A1 (en) * 1997-03-28 1998-10-08 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
EP1143941A3 (de) 2002-02-06
EP1143941A2 (de) 2001-10-17
JP2002534440A (ja) 2002-10-15
SK9502001A3 (en) 2002-05-09
CN1342078A (zh) 2002-03-27
TR200102019T2 (tr) 2002-04-22
PL350128A1 (en) 2002-11-04
WO2000041473A2 (de) 2000-07-20
CA2360366A1 (en) 2000-07-20
CZ20012380A3 (cs) 2002-01-16
NO20013464D0 (no) 2001-07-12
IL143795A0 (en) 2002-04-21
BR0007491A (pt) 2001-11-20
AU2436600A (en) 2000-08-01
WO2000041473A3 (de) 2001-11-29
HUP0105412A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
NO971471L (no) Nye karboksamider med fungicid aktivitet
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
PE20001297A1 (es) Antibioticos cetolidos carbamato y carbazato
NO20040881L (no) Orale antidiabetes midler.
DE69617005T2 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
MXPA02006051A (es) Compuestos de amonio cuaternario ciclico.
EA200100586A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
WO2000044358A3 (de) Verwendung von phosphororganischen verbindungen zur prophylaktischen und therapeutischen behandlung von infektionen
SE9704770D0 (sv) New use
WO2003017766A3 (de) Herbizide auf basis von substituierten arylketonen
EA200100585A1 (ru) Применение производных фосфономуравьиной кислоты для лечения инфекций
ATE247903T1 (de) Fungizide zusammensetzung enthaltend ein n- benzoyl-n'-phenyl-harnstoff derivat
CY1105454T1 (el) Αντοχολοστατικη δραστικοτητα λουτεολινης, apigenin και naringenin
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
RU2001119804A (ru) Средство для подавления роста сульфатвосстанавливающих бактерий

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application